These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23473653)

  • 1. The effect of providing patient-specific electronically monitored antipsychotic medication adherence results on the treatment planning of prescribers of outpatients with schizophrenia.
    Nakonezny PA; Byerly MJ; Pradhan A
    Psychiatry Res; 2013 Jun; 208(1):9-14. PubMed ID: 23473653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia.
    Byerly MJ; Thompson A; Carmody T; Bugno R; Erwin T; Kashner M; Rush AJ
    Psychiatr Serv; 2007 Jun; 58(6):844-7. PubMed ID: 17535946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
    Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
    Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.
    Nakonezny PA; Byerly MJ
    Schizophr Res; 2006 Feb; 82(1):107-14. PubMed ID: 16376522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief interventions for improving adherence in schizophrenia: A pilot study using electronic medication event monitoring.
    Tessier A; Dupuy M; Baylé FJ; Herse C; Lange AC; Vrijens B; Schweitzer P; Swendsen J; Misdrahi D
    Psychiatry Res; 2020 Mar; 285():112780. PubMed ID: 31954541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
    Nakonezny PA; Byerly MJ; Rush AJ
    Psychiatry Res; 2008 Jan; 157(1-3):259-63. PubMed ID: 17935793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
    Byerly MJ; Fisher R; Carmody T; Rush AJ
    J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE study.
    Gutiérrez-Casares JR; Cañas F; Rodríguez-Morales A; Hidalgo-Borrajo R; Alonso-Escolano D
    CNS Spectr; 2010 May; 15(5):327-37. PubMed ID: 20448523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders.
    Dolder CR; Lacro JP; Jeste DV
    Psychosom Med; 2003; 65(1):156-62. PubMed ID: 12554828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for improving treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC; Hill M; Freudenreich O
    J Clin Psychiatry; 2010; 71 Suppl 2():20-6. PubMed ID: 21190649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.
    Patterson TL; Lacro J; McKibbin CL; Moscona S; Hughs T; Jeste DV
    J Clin Psychopharmacol; 2002 Feb; 22(1):11-9. PubMed ID: 11799337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia.
    Achtyes E; Simmons A; Skabeev A; Levy N; Jiang Y; Marcy P; Weiden PJ
    BMC Psychiatry; 2018 Sep; 18(1):292. PubMed ID: 30223804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.
    Vassileva I; Milanova V; Asan T
    Community Ment Health J; 2014 Oct; 50(7):854-61. PubMed ID: 24452824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community adherence to schizophrenia treatment and safety monitoring guidelines.
    Keller WR; Fischer BA; McMahon R; Meyer W; Blake M; Buchanan RW
    J Nerv Ment Dis; 2014 Jan; 202(1):6-12. PubMed ID: 24375205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.
    Diaz E; Levine HB; Sullivan MC; Sernyak MJ; Hawkins KA; Cramer JA; Woods SW
    J Psychiatry Neurosci; 2001 Sep; 26(4):325-9. PubMed ID: 11590972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs).
    Beebe LH; Smith K; Phillips C
    Arch Psychiatr Nurs; 2016 Jun; 30(3):400-5. PubMed ID: 27256948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.